Search academic texts

Information × Registration Number 0214U003259, 0111U002098 , R & D reports Title To work out bases for the technology of complex using the therapeutic recobinant proteins to restore the blood flow of ischemic kidney popup.stage_title Head Vozianov O.F., Registration Date 27-01-2014 Organization Institute of Urology AMS of Ukraine popup.description2 The injection of risk factor preparations the FGF fibroblasts by 5 mcg dose, interleukin 10 Inl-10 by 5 mcg and 10 mcg doses and stromal cell factor SDF 1a by 10 mcg dose separately or in combination after 2 - 2.5 month ischemia lessens considerably the initial changes in parenchyma, stroma and vessels, and prevents the development of irreversible sclerotic changes of stroma and vessels and also defends against the spread of dystrophic destructive changes and the atrophy of renal parenchyma elements both in the kidney under study and in contralateral one after 7 - 8 month ischemia. Product Description popup.authors Возіанов О.Ф. Кордюм В.А. Нікітаєв С.В. Нікуліна Г.Г. Пирогов В.О. Романенко А.М. popup.nrat_date 2020-04-02 Close